Healthcare >> CEO Interviews >> October 12, 2001
HARVEY J. BERGER is ARIAD's principal founder and has served as its
Chairman and Chief Executive Officer since April 1991. From 1986 to
1991, Dr. Berger held a series of senior management positions at
Centocor, Inc., a biotechnology company, most recently as Executive Vice
President and President, Research and Development Division. He also has
held senior academic and administrative appointments at Emory
University, Yale University and the University of Pennsylvania and was
an Established Investigator of the American Heart Association. Dr.
Berger received his AB degree in Biology from Colgate University and his
MD degree from Yale University School of Medicine and did further
medical and research training at the Massachusetts General Hospital and
Yale-New Haven Hospital. Profile
now?
Dr. Berger: ARIAD is developing pharmaceutical products based upon
small-molecule drugs and our proprietary gene
